The Company’s potentially dilutive securities include options to purchase common stock, unvested shares of restricted stock units, the chief executive officer's 2021 RSU Award and 2023 RSU Award, and expected shares purchased under Employee Stock Purchase Plan. The Company's potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the

computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:


	December 31,
	2023		2022
Options to purchase common stock		7,811,231		8,053,704
Restricted stock units		1,416,446		927,954
Restricted stock units - executive officer		1,447,804		952,804
Employee Stock Purchase Plan (ESPP)		2,995		5,651
Total		10,678,476		9,940,113